AIDS News and Research

RSS

Texas Biomed receives DoD subcontracts to assess SARS-CoV-2 decontamination technologies

Texas Biomedical Research Institute received two Department of Defense's (DoD) Defense Health Agency subcontracts to assess the efficacy of surface coating and aerosolized decontamination technologies to combat SARS-CoV-2 and other respiratory pathogens on surfaces and in the air.

11 Mar 2021

One in four people could face some degree of hearing loss by 2050, WHO report warns

One in four people across the world — nearly 2.5 billion — could face some degree of hearing loss by 2050 with at least 700 million requiring access to treatment and rehabilitation, a WHO report warns.

11 Mar 2021

Study highlights the 'clear benefit' of using e-cigarettes daily to quit smoking

A new study published Tuesday 10 March, No Smoking Day, from King's College London highlights the 'clear benefit' of using e-cigarettes daily in order to quit smoking, and supports their effectiveness when compared to other methods of quitting, including nicotine replacement therapy or medication.

10 Mar 2021

Decision-making between patient and doctor is crucial before lung cancer screening

In a viewpoint perspective published in JAMA on March 9, 2021, a University of North Carolina Lineberger Comprehensive Cancer Center researcher and two other experts endorsed the Center for Medicare & Medicaid Services' (CMS) requirement for a patient and their doctor to engage in a shared discussion of benefits and harms before proceeding with a low-dose spiral computed tomography (LDCT) scan as a method for preventing lung cancer death.

10 Mar 2021

Expert insights from collaborative and commercial microbiome research studies

This webinar series is brought to you by APC Microbiome Ireland, and Atlantia Clinical Trials. Exciting times ahead as we announce this unique event, which will offer industry professionals the opportunity to gain insights not found elsewhere.

From Atlantia Clinical Trials 9 Mar 2021

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.

8 Mar 2021

Inflammation linked to intensity of tobacco smoking among HIV-positive people

Inflammation in the body has been linked to the intensity of tobacco smoking among people with HIV, according to a team of University of Massachusetts Amherst researchers.

8 Mar 2021

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

An innovative cell-based treatment for cancer has been found promising for the control of infections caused by fungi.

4 Mar 2021

New poll spotlights a major gap in testing for hearing loss in older adults

Eighty percent of Americans over 50 say their primary care doctor hasn't asked about their hearing in the past two years, and nearly as many - 77% -- haven't had their hearing checked by a professional in that same time, according to a new national poll report.

2 Mar 2021

Experimental therapy delays viral rebound in SHIV-infected macaques

A recent preclinical study by U.S. Military HIV Research Program (MHRP) researchers showed that an experimental therapy combining a TLR7 agonist and two broadly neutralizing antibodies delayed viral rebound in SHIV-infected macaques after antiretroviral therapy (ART) interruption.

2 Mar 2021

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.

1 Mar 2021

Black churches fill a unique role in combating vaccine fears

In the hospital with covid-19 in December, Lavina Wafer tired of the tubes in her nose and wondered impatiently why she couldn't be discharged. A phone call with her pastor helped her understand that the tube was piping in lifesaving oxygen, which had to be slowly tapered to protect her.

1 Mar 2021

New SARS-CoV-2 B.1.526 variant emerges in New York

New York has the first case of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant called B.1.526, picked up by genomic surveillance research from Columbia University. The findings come after reports of other variants have been reported worldwide — B.1.1.7 in the United Kingdom, B.1.351 in South Africa, and P.1/P.2 in Brazil.

28 Feb 2021

Biden’s straight-talking CDC director has long used data to save lives

In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout.

26 Feb 2021

New tool predicts trends and outcomes in individual patients

Clinical research requires that data be mined for insights. Machine learning, which develops algorithms to find patterns, has difficulty doing this with data related to health records because this type of information is neither static nor regularly collected.

26 Feb 2021

Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease

Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.

25 Feb 2021

Study explores the effects of COVID-19 on Black and Latino individuals living with HIV

With the COVID-19 pandemic taking a disproportionate toll on low-income people of color, a research team headed by Marya Gwadz of the Silver School of Social Work at New York University set out to understand the ways the pandemic may put individuals at risk for adverse outcomes, and the ways they successfully adapted to and coped with the emerging pandemic, focused on those from low-socioeconomic status backgrounds who have lived with HIV for a decade or longer.

22 Feb 2021

Genetic mechanism enables TB-causing bacterium to remember and rapidly respond to stress

Tuberculosis bacteria have evolved to remember stressful encounters and react quickly to future stress, according to a study by computational bioengineers at Rice University and infectious disease experts at Rutgers New Jersey Medical School (NJMS).

22 Feb 2021

UH receives funding from Gilead Sciences to fight against HIV/AIDS epidemic

A University of Houston Graduate College of Social Work research center working to eradicate the underlying serious and systemic challenges that contribute to the HIV/AIDS epidemic in the Southern United States has received $5 million in renewal funding from biopharmaceutical company Gilead Sciences, Inc. to facilitate the continuation of its impactful work.

22 Feb 2021

HIV-positive people with severe immunosuppression, APOE4 gene may have increased risk for dementia

People living with the human immunodeficiency virus (HIV) who have a history of severe immunosuppression and at least one copy of the Alzheimer's disease-related gene variant APOE4, might see a compounded adverse effect on the circuitry that impacts memory.

22 Feb 2021

AIDS News and Research

Texas Biomed receives DoD subcontracts to assess SARS-CoV-2 decontamination technologies

One in four people could face some degree of hearing loss by 2050, WHO report warns

Study highlights the 'clear benefit' of using e-cigarettes daily to quit smoking

Decision-making between patient and doctor is crucial before lung cancer screening

Expert insights from collaborative and commercial microbiome research studies

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

Inflammation linked to intensity of tobacco smoking among HIV-positive people

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

New poll spotlights a major gap in testing for hearing loss in older adults

Experimental therapy delays viral rebound in SHIV-infected macaques

Researchers develop mutant gene-targeted immunotherapy approach to fight cancers

Black churches fill a unique role in combating vaccine fears

New SARS-CoV-2 B.1.526 variant emerges in New York

Biden’s straight-talking CDC director has long used data to save lives

New tool predicts trends and outcomes in individual patients

Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease

Study explores the effects of COVID-19 on Black and Latino individuals living with HIV

Genetic mechanism enables TB-causing bacterium to remember and rapidly respond to stress

UH receives funding from Gilead Sciences to fight against HIV/AIDS epidemic

HIV-positive people with severe immunosuppression, APOE4 gene may have increased risk for dementia

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News